Condensed Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
REVENUE:
Total revenue	$ 0	$ 144	$ 0	$ 334
COSTS AND EXPENSES:
Research and development	9,923	10,004	17,760	22,221
General and administrative	13,175	10,580	30,863	19,646
Total costs and expenses	23,098	20,584	48,623	41,867
LOSS FROM OPERATIONS	(23,098)	(20,440)	(48,623)	(41,533)
OTHER INCOME (EXPENSE), NET:
Interest income	364	628	985	1,215
Change in fair value of warrant liabilities	1,437	22,744	4,541	(40,660)
Other expense	(33)	(34)	(58)	(62)
Total other income (expense), net	1,768	23,338	5,468	(39,507)
Net income (loss)	$ (21,330)	$ 2,898	$ (43,155)	$ (81,040)
Net loss per share attributable to common stockholders - basic	$ (0.15)	$ 0.02	$ (0.3)	$ (0.6)
Net loss per share attributable to common stockholders - diluted	$ (0.15)	$ (0.13)	$ (0.3)	$ (0.6)
Weighted-average common stock outstanding - basic	145,091,474	143,934,239	144,940,561	134,627,942
Weighted-average common stock outstanding - diluted	145,091,474	152,392,748	144,940,561	134,627,942
Research and development services
REVENUE:
Total revenue	$ 0	$ 144	$ 0	$ 334